Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Bekker, A; Schaaf, H S; Draper, H R; van der Laan, L; Murray, S; Wiesner, L; Donald, P R; McIlleron, H M; Hesseling, A C.
Antimicrob Agents Chemother
; 60(4): 2171-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26810651
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.